Pricing Log in Create free account

ENDRA Life Sciences Inc. (NDRA) vs ProPhase Labs, Inc. (PRPH)

ENDRA Life Sciences Inc. and ProPhase Labs, Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.7M against $1.2M — 6.5× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −717.4%) and the lower return on invested capital (−539.9% vs −387.3%). Across the 15 metrics below, ProPhase Labs, Inc. leads on 8 and ENDRA Life Sciences Inc. on 7.

Valuation

Metric NDRA PRPH Diagnostics & Research median
P/E n/m n/m 35.56
P/S 17.54 0.04 4.37
P/B 0.99 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 2.22 1.84 5.51
Earnings yield (133.33%) (23,896.00%) (1.89%)
Free cash flow yield (124.95%) (3,945.49%) (0.15%)

Profitability

Metric NDRA PRPH Diagnostics & Research median
Gross margin 0.00% 16.38% 50.89%
Operating margin 0.00% (498.73%) (8.57%)
Net margin 0.00% (717.43%) (6.37%)
Free cash flow margin 0.00% (175.22%) 0.00%
Return on equity (152.04%) (543.95%) (2.92%)
Return on assets (110.08%) (45.53%) (6.71%)
Return on invested capital (539.89%) (387.30%) 0.00%

Growth

Metric NDRA PRPH Diagnostics & Research median
Revenue growth (TTM) — (43.52%) 7.69%
EPS growth (last fiscal year) 84.32% 93.33% 25.92%
Revenue growth, 5-year CAGR — (21.43%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA PRPH Diagnostics & Research median
Debt to equity 0.00 (1.82) 0.11
Current ratio 7.10 0.05 2.02
Net debt to EBITDA 0.14 (0.74) 0.70

Dividend

Metric NDRA PRPH Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric NDRA PRPH Diagnostics & Research median
Market cap 7.65m 1.17m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack